American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • Industry

PhRMA hosts dialogue on national health care

American Pharmacy News Reports | Mar 4, 2017
The event was held to promote conversation about changes in patient care and science.

The Pharmaceutical Research and Manufacturers of American (PhRMA) recently sponsored "Through the Microscope: Examining Modern Medicine," its first national health care dialogue series.  Read More »

3M Drug Delivery Systems undertakes new phase with Panacea Pharmaceuticals

American Pharmacy News Reports | Mar 4, 2017
The hMTS delivery method has various benefits in addition to the superior immune response.

3M Drug Delivery Systems will continue its collaboration with Panacea Pharmaceuticals Inc., this time working on a new phase in its study of an investigational therapeutic cancer vaccine that would be delivered to the dermis via 3M's Hollow Microstructured Transdermal System. Read More »

Data shows CVS spearheaded nationwide decline in tobacco sales

Carrie Bradon | Mar 1, 2017
CVS Health's removal of tobacco products from its stores has made positive changes on the buying habits of the public. 

CVS Health Research Institute recently released a statement on its decision to stop selling tobacco products and the research behind that decision.  Read More »

Biogen spins off Bioverativ with focus on hemophilia

American Pharmacy News Reports | Mar 1, 2017
Biogen shareholders automatically received stock in Bioverativ.  

Biogen Inc., a global pharmaceutical manufacture, has launched a subsidiary global hemophilia business, Bioverativ. Read More »

Palatin seals license agreement with AMAG Pharmaceuticals

American Pharmacy News Reports | Mar 1, 2017
The license agreement accounted for an initial payment of $60 million to Palatin.

Palatin Technologies Inc. has closed its license agreement with AMAG Pharmaceuticals Inc. for the development of Rekynda in North America. Read More »

Portola Pharmaceuticals signs $150 million royalty agreement

American Pharmacy News Reports | Mar 1, 2017
Andexanat Alfa is an antidote for Factor Xa inhibitors.

Portola Pharmaceuticals recently signed a $150 million royalty agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanat Alfa, an antidote for  Factor Xa inhibitors. Read More »

Partnership to increase effectiveness of patient data integration

American Pharmacy News Reports | Feb 28, 2017
Precision for Value and the National Committee for Quality Assurance have partnered to integrate data.

Precision for Value and the National Committee for Quality Assurance have partnered to integrate data collected in the Healthcare Effectiveness Data and Information Set into the quality measuring tool Qnav.  Read More »

FDA rejects Daiichi Sankyo's application for pain medication

American Pharmacy News Reports | Feb 28, 2017
The FDA declared the application for CL-108, as it stands, not approved.

The FDA issued a complete response letter in response to Daiichi Sankyo's new drug application regarding CL-108, a drug used in treating and managing pain. Read More »

Allergan makes sizable donation to liver disease research

American Pharmacy News Reports | Feb 28, 2017
AASLD is the largest private supporter of hepatology research in the U.S.

Allergan has made a substantial donation to the American Association for the Study of Liver Diseases Foundation, becoming part of AASLD’s Founder’s Society. Read More »

Drug Channels ranks top 15 U.S. pharmacies of 2016

American Pharmacy News Reports | Feb 25, 2017
CVS Health Corp. generated an estimated $96.4 billion in prescription revenue for 2016.

The recent 2017 Economic Report on Pharmacies and Pharmacy Benefit Managers by Drug Channels named the top 15 U.S. Pharmacies of 2016.  Read More »

AbbVie submits New Drug Application for Hepatitis C treatment

American Pharmacy News Reports | Feb 25, 2017
These studies considered a pool of over 2,300 patients throughout 27 countries over all of the major HCV genotypes.

The U.S. Food and Drug Association is reviewing AbbieVie's New Drug Application (NDA) for a new treatment of Hepatitis C virus.  Read More »

HealthQx attains Prometheus Analytics certification

American Pharmacy News Reports | Feb 23, 2017
The episodes cover topics of behavioral health and oncology.

McKesson Health Solutions, a company that specializes in helping patients with medical payments, recently announced its new analytics system HealthQx received certification in the Prometheus Analytics model. Read More »

Medac passes Service Organization Control 2 certification

American Pharmacy News Reports | Feb 22, 2017
The SOC 2 Type 2 process ensures that Medac is cyber secure.

Medical business management service provider Medac Inc. has completed a Service Organization Control 2 certification. Read More »

GSK launches Flonase ahead of allergy season

American Pharmacy News Reports | Feb 22, 2017
GSK Consumer Healthcare has launched Flonase Allergy Relief.

GSK Consumer Healthcare has launched Flonase Allergy Relief for the treatment of seasonal allergies. Read More »

Mylan to host Investor Day

American Pharmacy News Reports | Feb 22, 2017
CEO Heather Bresch and other senior leaders will present on the company’s financial guidance.

Global pharmaceutical maker Mylan will host Investor Day on March 1 in New York City. Read More »

CDC offers flu-prevention tips

American Pharmacy News Reports | Feb 21, 2017
The CDC reminds the nation that the flu vaccine is the best defense against contracting the disease.

The Centers for Disease Control and Prevention has releases detailed information on the risks that flu season presents.  Read More »

AbbVie to present at Cowen and Co. Health Care Conference

American Pharmacy News Reports | Feb 20, 2017
For those unable to log on at the time of the conference, an archived copy of the recording will be available.

AbbVie, a global biopharmaceutical company focused on research, will take part in the upcoming Cowen and Company 37th Annual Health Care Conference.  Read More »

Conference to highlight patient accessibility, co-pays

American Pharmacy News Reports | Feb 18, 2017
Discussions concerning reimbursement of expensive therapeutics will take place.

CBI's Formulary, Co-Pay and Access Summit will convene April 11-12 to address patient affordability barriers and more.  Read More »

Arbitration panel awards $35 million to GlaxoSmithKline

American Pharmacy News Reports | Feb 18, 2017
The tribunal denied Pernix's claim concerning GSK's alleged breach of contract.

GlaxoSmithKline was awarded damages, fees and interest on Jan. 31 as arbitration concluded with Pernix Therapeutics Holdings Inc.  Read More »

Evidence building of PBMs' ability to control Rx costs

LocalLabs News Service | Feb 17, 2017

Prime Therapeutics releases report showing it held drug costs increases to just 2.5 percent for its clients in 2015. Read More »

  • «
  • 1
  • 2
  • ...
  • 22
  • 23
  • 24 (current)
  • 25
  • 26
  • ...
  • 32
  • 33
  • »
Trending

Brianna Allen, Senior Director of Public Affairs at PhRMA

PhRMA senior director on 340B program: 'Hospitals abuse the program to boost their profits at the expense of patients'

Molly Jenkins, Director of Public Affairs for PhRMA

PhRMA director of public affairs on 340B exploitation: ‘Evidence shows that 340B entities markup medicines by as much 1,000% or more’

Dan DeNeui, CEO of FarmaKeio

Iowa board files charges against FarmaKeio, citing FDA and California actions

Luke Gale, Revenue Cycle Editor, HealthLeaders Media

HealthLeaders editor on 340B: ‘We continue to have serious concerns about persistent and often illegal abuse of 340B’

Lenora S. Newsome PD Chairperson

Potential medication mix-ups between Inflectra and Zymfentra prompt safety warnings

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up